Prognostic Factors in Patients with Advanced HER2-Positive Gastric Cancer Treated with Trastuzumab-Based Chemotherapy: a Cohort Study

被引:0
|
作者
Shoko Marshall
Takeru Wakatsuki
Daisuke Takahari
Tomohiro Matsushima
Naoki Ishizuka
Izuma Nakayama
Hiroki Osumi
Mariko Ogura
Takashi Ichimura
Eiji Shinozaki
Keisho Chin
Kensei Yamaguchi
机构
[1] Tokyo Women’s Medical University Medical Center East,Department of Medicine
[2] Cancer Institute Hospital of the Japanese Foundation for Cancer Research,Department of Gastrointestinal Oncology
[3] Saitama Cancer Center,Department of Gastroenterology
[4] Department of Clinical Trial Planning and Management,undefined
[5] Clinical Research & Medical Development Center,undefined
来源
Journal of Gastrointestinal Cancer | 2023年 / 54卷
关键词
HER2; Gastric cancer; Trastuzumab; Prognostic factor; Visceral metastasis; Low hemoglobin; High LDH; High CRP;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:475 / 484
页数:9
相关论文
共 50 条
  • [1] Prognostic Factors in Patients with Advanced HER2-Positive Gastric Cancer Treated with Trastuzumab-Based Chemotherapy: a Cohort Study
    Marshall, Shoko
    Wakatsuki, Takeru
    Takahari, Daisuke
    Matsushima, Tomohiro
    Ishizuka, Naoki
    Nakayama, Izuma
    Osumi, Hiroki
    Ogura, Mariko
    Ichimura, Takashi
    Shinozaki, Eiji
    Chin, Keisho
    Yamaguchi, Kensei
    JOURNAL OF GASTROINTESTINAL CANCER, 2023, 54 (02) : 475 - 484
  • [2] Pathologic Response of HER2-positive Gastric Cancer to Trastuzumab-based Chemotherapy
    Urabe, Masayuki
    Ushiku, Tetsuo
    Seto, Yasuyuki
    Fukayama, Masashi
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2016, 40 (10) : 1326 - 1333
  • [3] MicroRNAs as biomarkers for trastuzumab-based therapy in HER2-positive advanced oesophago-gastric cancer patients
    Lote, Hazel
    Mousoullou, Florentia
    Vlachogiannis, George
    Lampis, Andrea
    Satchwell, Laura
    Peckitt, Clare
    Fong, Caroline
    Begum, Ruwaida
    Kidd, Shannon
    Cromarty, Susan
    Gordon, Anderley
    Fribbens, Charlotte
    Rao, Sheela
    Starling, Naureen
    Chau, Ian
    Cunningham, David
    Valeri, Nicola
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [4] A prospective observational study on the optimal maintenance strategy in HER2-positive advanced gastric cancer treated with trastuzumab-based therapy
    Li, Qian
    Lv, Minzhi
    Jiang, Huiqin
    Wang, Yan
    Yu, Shan
    Li, Wei
    Yu, Yiyi
    Liu, Tianshu
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (01) : 287 - 295
  • [5] A prospective observational study on the optimal maintenance strategy in HER2-positive advanced gastric cancer treated with trastuzumab-based therapy
    Qian Li
    Minzhi Lv
    Huiqin Jiang
    Yan Wang
    Shan Yu
    Wei Li
    Yiyi Yu
    Tianshu Liu
    Journal of Cancer Research and Clinical Oncology, 2020, 146 : 287 - 295
  • [6] Depth of response predicts the clinical outcome of advanced HER2-positive gastric cancer to trastuzumab-based first-line chemotherapy
    Kadowaki, Shigenori
    Masuishi, Toshiki
    Eto, Tetsuya
    Narita, Yukiya
    Taniguchi, Hiroya
    Ura, Takashi
    Ando, Masashi
    Tajika, Masahiro
    Niwa, Yasumasa
    Yatabe, Yasushi
    Muro, Kei
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 80 (04) : 807 - 813
  • [7] Predictive factors of trastuzumab-based chemotherapy in HER2 positive advanced gastric cancer: a single-center prospective observational study
    Li, Q.
    Li, H.
    Jiang, H.
    Feng, Y.
    Cui, Y.
    Wang, Y.
    Ji, Y.
    Yu, Y.
    Li, W.
    Xu, C.
    Yu, S.
    Zhuang, R.
    Liu, T.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 20 (06) : 695 - 702
  • [8] Predictive factors of trastuzumab-based chemotherapy in HER2 positive advanced gastric cancer: a single-center prospective observational study
    Q. Li
    H. Li
    H. Jiang
    Y. Feng
    Y. Cui
    Y. Wang
    Y. Ji
    Y. Yu
    W. Li
    C. Xu
    S. Yu
    R. Zhuang
    T. Liu
    Clinical and Translational Oncology, 2018, 20 : 695 - 702
  • [9] Successful Use of Trastuzumab with Anthracycline-based Chemotherapy Followed by Trastuzumab Maintenance in Patients with Advanced HER2-positive Gastric Cancer
    Palacio, Sofia
    Loaiza-Bonilla, Arturo
    Kittaneh, Muaiad
    Kyriakopoulos, Christos
    Ochoa, Roberto E.
    Escobar, Mauricio
    Arango, Belisario
    Restrepo, Maria H.
    Merchan, Jaime R.
    Lima, Caio M. S. Rocha
    Hosein, Peter J.
    ANTICANCER RESEARCH, 2014, 34 (1A) : 301 - 306
  • [10] Predictive Roles of HER2 Gene Amplification and Neutrophil-to-Lymphocyte Ratio on Survival in HER2-Positive Advanced Gastric Cancer Treated With Trastuzumab-Based Chemotherapy
    Park, Joo-Hwan
    Yeo, Ja Hyun
    Kim, Young Saing
    Park, Inkeun
    Ahn, Hee Kyung
    Shin, Dong Bok
    Lee, Woon-Ki
    Yang, Jun-Young
    Kim, Hyung-Sik
    Sym, Sun Jin
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2021, 44 (06): : 232 - 238